Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting
Clinical trial NCT04501952 · TERMINATED
Trial details
- NCT number
- NCT04501952
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-18
- Primary completion
- 2021-05-06
- Enrollment
- 584
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.